Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

STEPS Trial - Spheramine Safety and Efficacy Study

This study has been terminated.
(Study was completed, only life long extended follow-up phase was discontinued after 12 years.)
Sponsor:
Collaborator:
Titan Pharmaceuticals
Information provided by:
Bayer
ClinicalTrials.gov Identifier:
NCT00206687
First received: September 13, 2005
Last updated: September 23, 2015
Last verified: November 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: May 2012
  Primary Completion Date: May 2012 (Final data collection date for primary outcome measure)
  Certification or Request for Extension to Delay Results Received: September 23, 2015